Literature DB >> 7858870

The effect of hyperglycaemia on function of rat isolated mesenteric resistance artery.

P D Taylor1, L Poston.   

Abstract

1. Noradrenaline sensitivity and acetylcholine-induced relaxation were investigated in mesenteric resistance arteries from female Wistar rats (220-250 g) following exposure to isotonic supraphysiological glucose solutions (20 and 45 mM, in physiological buffer, 2 h incubation). 2. Arteries incubated in 20 mM glucose demonstrated enhanced noradrenaline sensitivity compared with those in physiological buffer. 3. Profoundly impaired endothelium-dependent relaxation to acetylcholine was observed in arteries incubated in 20 and 45 mM glucose. 4. Indomethacin (10 microM) normalized noradrenaline sensitivity in 20 mM glucose, but unmasked an enhanced maximum response in 20 and 45 mM glucose relative to controls. 5. Addition of L-arginine (0.1 mM) prevented the abnormality of acetylcholine-induced relaxation in the 20 mM glucose medium and significantly improved relaxation in 45 mM glucose. 6. The aldose reductase inhibitor, ponalrestat (10(-5) M, ZENECA Pharmaceuticals), prevented impaired acetylcholine-mediated relaxation in 20 mM glucose and significantly improved relaxation in 45 mM glucose. 7. Indomethacin (10 microM) improved maximum relaxation but did not alter impaired sensitivity to acetylcholine in the high glucose media (20 and 45 mM). 8. Superoxide dismutase (SOD, 150 u ml-1) also prevented impaired acetylcholine-induced relaxation in 20 mM glucose but not in 45 mM glucose. 9. Endothelium-independent relaxation to sodium nitroprusside (SNP, 10(-9)-10(-5) mM) was normal in 20 mM glucose but was slightly, although significantly impaired by 45 mM glucose. 10. Enhanced responsiveness of rat isolated mesenteric resistance arteries to noradrenaline caused by elevated glucose would appear to be mediated through abnormal cyclo-oxygenase activity and the reduced tonic release of nitric oxide. 11. Hyperglycaemia may lead to abnormal endothelium-dependent relaxation in these arteries through several mechanisms which include a role for increased free radical production, polyol pathway activation and altered L-arginine metabolism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7858870      PMCID: PMC1510412          DOI: 10.1111/j.1476-5381.1994.tb17064.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  48 in total

1.  Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.

Authors:  M J Mulvany; W Halpern
Journal:  Circ Res       Date:  1977-07       Impact factor: 17.367

2.  Possible involvement of S-nitrosothiols in the activation of guanylate cyclase by nitroso compounds.

Authors:  L J Ignarro; J C Edwards; D Y Gruetter; B K Barry; C A Gruetter
Journal:  FEBS Lett       Date:  1980-02-11       Impact factor: 4.124

3.  Enhancement of alpha-1 and alpha-2 adrenergic agonist-induced vasoconstriction by removal of endothelium in rat aorta.

Authors:  G O Carrier; R E White
Journal:  J Pharmacol Exp Ther       Date:  1985-03       Impact factor: 4.030

4.  Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes.

Authors:  S P Wolff; R T Dean
Journal:  Biochem J       Date:  1987-07-01       Impact factor: 3.857

Review 5.  Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications.

Authors:  D A Greene; S A Lattimer; A A Sima
Journal:  N Engl J Med       Date:  1987-03-05       Impact factor: 91.245

6.  Attenuation of endothelium-dependent relaxation in aorta from diabetic rats.

Authors:  Y Oyama; H Kawasaki; Y Hattori; M Kanno
Journal:  Eur J Pharmacol       Date:  1986-12-02       Impact factor: 4.432

7.  The influence of streptozotocin-induced diabetes mellitus on fluid and electrolyte handling in rats.

Authors:  R A Hebden; S M Gardiner; T Bennett; I A MacDonald
Journal:  Clin Sci (Lond)       Date:  1986-01       Impact factor: 6.124

8.  The influence of chronic experimental diabetes on contractile responses of rat isolated blood vessels.

Authors:  K M MacLeod; J H McNeill
Journal:  Can J Physiol Pharmacol       Date:  1985-01       Impact factor: 2.273

9.  Prevention by insulin treatment of endothelial dysfunction but not enhanced noradrenaline-induced contractility in mesenteric resistance arteries from streptozotocin-induced diabetic rats.

Authors:  P D Taylor; B B Oon; C R Thomas; L Poston
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

10.  Intestinal hyperemia in experimental diabetes mellitus.

Authors:  R J Korthuis; J N Benoit; P R Kvietys; M H Laughlin; A E Taylor; D N Granger
Journal:  Am J Physiol       Date:  1987-07
View more
  21 in total

Review 1.  Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction.

Authors:  Csaba Szabo
Journal:  Br J Pharmacol       Date:  2009-02-06       Impact factor: 8.739

Review 2.  Molecular insights and therapeutic targets for diabetic endothelial dysfunction.

Authors:  Jian Xu; Ming-Hui Zou
Journal:  Circulation       Date:  2009-09-29       Impact factor: 29.690

3.  Changes in superoxide dismutase mRNA expression by streptozotocin-induced diabetes.

Authors:  K Kamata; T Kobayashi
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

4.  Contraction and relaxation of aortas from diabetic rats: effects of chronic anti-oxidant and aminoguanidine treatments.

Authors:  V Archibald; M A Cotter; A Keegan; N E Cameron
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-04       Impact factor: 3.000

5.  Early and intermediate Amadori glycosylation adducts, oxidative stress, and endothelial dysfunction in the streptozotocin-induced diabetic rats vasculature.

Authors:  L Rodríguez-Mañas; J Angulo; S Vallejo; C Peiró; A Sánchez-Ferrer; E Cercas; P López-Dóriga; C F Sánchez-Ferrer
Journal:  Diabetologia       Date:  2003-03-12       Impact factor: 10.122

6.  Nitric oxide production by the human intestinal microbiota by dissimilatory nitrate reduction to ammonium.

Authors:  Joan Vermeiren; Tom Van de Wiele; Willy Verstraete; Pascal Boeckx; Nico Boon
Journal:  J Biomed Biotechnol       Date:  2009-11-01

7.  Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress.

Authors:  O Brouwers; P M Niessen; G Haenen; T Miyata; M Brownlee; C D Stehouwer; J G De Mey; C G Schalkwijk
Journal:  Diabetologia       Date:  2010-02-26       Impact factor: 10.122

8.  Argininosuccinate synthetase is a functional target for a snake venom anti-hypertensive peptide: role in arginine and nitric oxide production.

Authors:  Juliano R Guerreiro; Claudiana Lameu; Eduardo F Oliveira; Clécio F Klitzke; Robson L Melo; Edlaine Linares; Ohara Augusto; Jay W Fox; Ivo Lebrun; Solange M T Serrano; Antonio C M Camargo
Journal:  J Biol Chem       Date:  2009-06-02       Impact factor: 5.157

9.  Differential effects of glucose on agonist-induced relaxations in human mesenteric and subcutaneous arteries.

Authors:  A MacKenzie; E J Cooper; F J Dowell
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

10.  Effect of diabetes and elevated glucose on nitric oxide-mediated neurotransmission in rat anococcygeus muscle.

Authors:  K J Way; J J Reid
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.